CAPITOL HILL CONSULTING GROUP

Lobbying for OCULAR THREPEUTIX · Biopharmaceutical company focused on therapies for the eye.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $20,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Medicare/Medicaid

Issues related to Medicare reimbursement for therapies of the eye.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.